XML 32 R19.htm IDEA: XBRL DOCUMENT v3.5.0.2
Note 13 - Equity Transactions and Stock-based Compensation
12 Months Ended
Jun. 30, 2016
Notes to Financial Statements  
Stockholders' Equity Note Disclosure [Text Block]
Note 1
3
. Equity Transactions
and Stock-Based Compensation
 
Stock Option Plan.
The Company has adopted a stock option plan for the granting of options or restricted shares to employees, officers, directors and consultants of the Company that originally provided for the purchase of up to 7,000,000 shares of common stock, at the discretion of the Board of Directors. Subsequent to the adoption, the Board of Directors and stockholders approved additional common stock shares aggregating 6,000,000 to be available for grant, for a total of 13,000,000 shares of common stock reserved for issuance under the Company’s 2001 Stock Option Plan, as amended. Stock option grants may not be priced less than the fair market value of the Company’s common stock at the date of grant. Options granted are generally for ten-year periods, except that incentive stock options granted to a 10% stockholder (as defined) are limited to five-year terms.
 
In June, 2015, there were 2,248,000 stock options authorized by the Board of Directors and issued to Company officers, employees and directors with an exercise price ranging from $0.09 to $0.10, vesting over three years, with terms of either five or ten years.
During the fiscal year ended June 30, 2016 and 2015, the Company incurred stock compensation expense of approximately $31 and $0.1 million, respectively. The Company expects to record additional stock compensation expense of approximately $35 over the estimated weighted average remaining vesting period of two years.
 
The Company calculates expected volatility for a stock-based grant based on historic daily stock price observations of
its common stock during the period immediately preceding the grant that is equal in length to the expected term of the grant. The expected term of the options is estimated based on the Company’s historical exercise rate and forfeiture rates are estimated based on employment termination experience. The risk free interest rate is based on U.S. Treasury yields for securities in effect at the time of grants with terms approximating the term of the grants. The assumptions used in the Black-Scholes option valuation model are highly subjective, and can materially affect the resulting valuations.
 
The following options and potentially dilutive shares for convertible notes payable
(see Note 6. Senior Credit Facility, Subordinated Convertible Note Payable, net - CD Financial, LLC and other Long Term Debt) were not included in the computation of weighted average diluted common shares outstanding as the effect of doing so would be anti-dilutive for fiscal years ended June 30, 2016 and 2015:
       
 
Fiscal Year Ended
 
June 30,
 
2016
 
2015
       
Anti-dilutive stock options
              694,950
 
        2,139,550
Anti-dilutive shares for
     
convertible notes payable
           8,230,769
 
                     -
Total anti-dilutive shares
           8,925,719
 
        2,139,550
 
 
The intrinsic value of options outstanding and exercisable at
June 30, 2016 and 2015 was $31 and $0, respectively.
 
A summary of the Company
’s stock option activity, and related information for the years ended June 30, follows:
         
       
Weighted
       
Average
       
Exercise
   
Options
 
Price
Outstanding as of July 1, 2014
 
     1,724,520
 
$ 4.07
Granted
 
     2,248,000
 
           0.09
Exercised
 
                  -
 
               -
Terminated
 
         (18,000)
 
           1.11
Expired
 
       (881,570)
 
           6.36
Outstanding as of June 30, 2015
 
     3,072,950
 
           0.52
Granted
 
                  -
 
               -
Exercised
 
                  -
 
               -
Terminated
 
         (80,000)
 
           0.17
Expired
 
       (122,000)
 
           3.63
Outstanding as of June 30, 2016
 
     2,870,950
 
$ 0.40
         
Exercisable at June 30, 2015
 
     2,164,550
 
$ 0.70
Exercisable at June 30, 2016
 
     2,383,617
 
$ 0.46
 
The following table summarizes the range of exercise prices and weighted-average exercise prices for stock options outstanding and exercisable as of
June 30, 2016 under the Company’s stock option plans:
 
               
Weighted
       
               
Average
       
           
Weighted
 
Remaining
     
Weighted
Range of
 
 
 
Average
 
Contractual
 
 
 
Average
Exercise Price
 
Outstanding
 
Exercise Price
 
Life (years)
 
Exercisable
 
Exercise Price
$ 0.09
-
$ 0.10
 
         2,176,000
 
$ 0.09
 
8.8
 
         1,688,667
 
$ 0.09
$ 0.14
-
$ 0.15
 
            469,750
 
0.14
 
2.5
 
            469,750
 
0.14
$ 3.05
-
$ 3.05
 
            169,600
 
3.05
 
1.4
 
            169,600
 
3.05
$ 3.36
-
$ 3.36
 
                4,500
 
3.36
 
1.4
 
                4,500
 
3.36
$ 6.80
-
$ 6.80
 
              49,600
 
6.80
 
0.5
 
              49,600
 
6.80
$ 7.48
-
$ 7.48
 
                1,500
 
7.48
 
0.5
 
                1,500
 
7.48
$ 0.09
-
$7.48
 
         2,870,950
 
$ 0.40
 
4.3
 
         2,383,617
 
$ 0.46